Cargando…
Efficacy, Safety, and Drug–Drug Interactions for Insomnia Therapy in COVID-19 Patients
Coronavirus disease-19 (COVID-19) is a systemic viral infection. COVID-19 patients show diverse clinical presentations ranging from asymptomatic, mild symptoms to severe symptoms characterized by severe respiratory distress. Sleep disorders or insomnia is one of the psychiatric problems that arise d...
Autores principales: | Saputra, Billy Dwi, Levita, Jutti, Mustarichie, Resmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789249/ https://www.ncbi.nlm.nih.gov/pubmed/35087274 http://dx.doi.org/10.2147/JMDH.S337053 |
Ejemplares similares
-
Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials
por: Diantini, Ajeng, et al.
Publicado: (2023) -
Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors
por: Zaira, Bena, et al.
Publicado: (2023) -
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
por: Susilawati, Elis, et al.
Publicado: (2023) -
Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV
por: Rohani, et al.
Publicado: (2023) -
Insomnia drug therapy in COVID-19 patients; a letter to editor
por: Rismanbaf, Ali
Publicado: (2020)